Allspring Global Investments Holdings, LLC Ab Cellera Biologics Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$7.31 - $11.18 $605,874 - $926,631	-82,883 Reduced 72.22%	31,877 $240,000
Q4 2022 Jan 23, 2023	SELL	$9.48 - $14.52 $15,869 - $24,306	-1,674 Reduced 1.44%	114,760 $0
Q3 2022 Oct 26, 2022	BUY	$9.2 - $13.68 $1.07 Million - $1.59 Million	116,434 New	116,434 $1.15 Million

Others Institutions Holding ABCL

# of Institutions

155

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$77.9 Million
0.76% of portfolio
Baillie Gifford & CO

12.9M
Shares

$36.5 Million
0.03% of portfolio
Voya Investment Management LLC Atlanta, GA

10.6M
Shares

$30.1 Million
0.03% of portfolio
Prosight Management, LP Dallas, TX

9.08M
Shares

$25.7 Million
6.31% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

4.59M
Shares

$13 Million
0.0% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account